Table 2 Association between plasma miR-107 levels and types of recurrence in PCa patients with pancreatectomy.

From: Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer

Ā 

n

Plasma miR-107 concentration

P-valuea

High

Low

Total

38

20

(40%)

18

(75%)

0.0041

Hematogenous recurrence

Ā Liver

9

2

(4%)

7

(29%)

0.0027

Ā Lung

4

3

(6%)

1

(4%)

0.7386

Ā Bone

2

1

(2%)

1

(4%)

0.6024

Lymphatic recurrence

13

7

(14%)

6

(25%)

0.2546

Peritoneal recurrence

6

5

(10%)

1

(4%)

0.3636

Local recurrence

4

2

(4%)

2

(8%)

0.4545

  1. aChi-square test. NOTE: significant values are in bold.